Medical Education Library

Treating Rosacea: Current Insights


A supplement to Skin & Allergy News. This supplement was funded by Galderma.


• Is it Rosacea?
• Managing Rosacea: Target Potential Triggers
• Treatment Options for Rosacea
• Newer Topical Formulations
• Surgical Therapies
• Summary

Faculty/Faculty Disclosures

Richard Odom, MD
Professor, Clinical Dermatology
University of California
San Francisco School of Medicine
San Francisco, California
Advisory committee for Johnson & Johnson.

Terry Arnold, MA, PA-C
Advanced Practice Consultants, LLC
Tulsa, Oklahoma
Speaker for Medicis; advisory board of Novartis, Warner-Chilcott; advisory board/speaker for Abbott Laboratories, Astellas, Collagenex; advisory board, speaker and consultant for Amgen, Coria Labs, Ranbaxy.

Stephen Brunton, MD
Adjunct Clinical Professor
Department of Family Medicine
University of North Carolina
Chapel Hill
Chapel Hill, North Carolina
Nothing to disclose.

Mary Knudtson, DNSc, NP
Professor, Family Medicine
Director of Family Nurse Practitioner Program
University of California, Irvine
Irvine, California
Speaker's bureau for Proctor & Gamble; consultant for sanofi aventis, Galderma.

John E. Wolf, Jr., MD, MA
Professor and Chairman
Department of Dermatology
Baylor College of Medicine
Houston, Texas
Consultant, speaker, and on the advisory board for Stiefel, PharmaDerm, Galderma, Medicis, Novartis, Warner-Chilcott, consultant for QLT and Peplin; speaker for Stiefel, sanofi-aventis (Dermik).

Copyright © 2008 Elsevier Inc.

To view the supplement, click the image above.

Next Article: